Pascal Peeters

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen, David Jenkins, F. Xavier Bosch et al. · The Lancet · 2007 · 1.3K citations

Vaccination, Vaccine Safety, Interim Analysis +9

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

Roman Prymula, Pascal Peeters, Viktor Chrobok et al. · The Lancet · 2006 · 639 citations

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both <i>Streptococcus pneumoniae</i> and non‐typable <i>Haemophilus influenzae</i>: a randomised double‐blind efficacy study

Roman Prymula, Pascal Peeters, Viktor Chrobok et al. · Clinical Otolaryngology · 2006 · 523 citations

Mucosal Vaccination, Antibiotics, Medicine +8

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults

Michel Moutschen, Philippe Léonard, Étienne Sokal et al. · Vaccine · 2007 · 173 citations

Vaccination, Vaccine Safety, Vaccine Development +9

Immunogenicity and Safety of the Eleven Valent Pneumococcal Polysaccharide-Protein D Conjugate Vaccine in Infants

Anu Nurkka, Jaana Joensuu, Isabelle Henckaerts et al. · The Pediatric Infectious Disease Journal · 2004 · 66 citations